LODOXAMIDE AS TROMETAMOL 1 MG/ML - search results

New Zealand - English - Medsafe (Medicines Safety Authority)

lomide

novartis new zealand ltd - lodoxamide trometamol 1.78 mg/ml equivalent to 1 mg/ml lodoxamide - eye drops, solution - 1 mg/ml - active: lodoxamide trometamol 1.78 mg/ml equivalent to 1 mg/ml lodoxamide excipient: benzalkonium chloride citric acid monohydrate disodium edetate dihydrate hydrochloric acid hypromellose mannitol purified water sodium citrate dihydrate sodium hydroxide tyloxapol - lomide eye drops 0.1% are indicated in the treatment of non-infectious allergic conjunctivitis (vernal conjunctivitis, giant papillary conjunctivitis and seasonal allergic conjunctivitis). the aetiologic factors are unknown, but common airborne allergens and contact lenses have been implicated. lodoxamide trometamol may be effective against other ocular diseases where type-i, ige-mediated hypersensitivity (or mast cells) play a major role in the inflammatory process. prophylactic use of lomide eye drops will assist in minimising the allergic symptoms associated with seasonal allergic conjunctivitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

lomide eye drops lodoxamide 1.0mg/ml (as trometamol) eye drops bottle

novartis pharmaceuticals australia pty ltd - lodoxamide trometamol, quantity: 1.78 mg/ml (equivalent: lodoxamide, qty 1 mg/ml) - eye drops, solution - excipient ingredients: citric acid monohydrate; hydrochloric acid; mannitol; disodium edetate; tyloxapol; purified water; sodium citrate dihydrate; benzalkonium chloride; sodium hydroxide; hypromellose - seasonal allergic conjunctivitis and vernal keratoconjunctivitis in adults and children four years of age and older. prophylactic use of lomide eye drops may help in the management of seasonal allergic conjunctivitis and assist in reducing the allergic symptoms.